Patents by Inventor Tracy Schmitz

Tracy Schmitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Potentiation of the immune response
    Publication number: 20080026007
    Abstract: A method for stimulating proliferation of T-cells containing cytoplasmic post-prolyl dipeptidase activity; the method, in one aspect, involves contacting the T-cells with an organic compound at a concentration below 10?8M, wherein the compound is characterized in that: (a) it is capable of crossing the membrane of T-cells to enter the cytoplasm, (b) it binds to the dipeptidase activity at a concentration of below 10?8M, and thus (c) stimulates proliferation of the T-cells at that concentration.
    Type: Application
    Filed: February 6, 2007
    Publication date: January 31, 2008
    Inventors: Brigitte Huber, Tracy Schmitz, Robert Underwood
  • Potentiation of the immune response
    Publication number: 20050008644
    Abstract: A method for stimulating proliferation of T-cells containing cytoplasmic post-prolyl dipeptidase activity; the method, in one aspect, involves contacting the T-cells with an organic compound at a concentration below 10?8M, wherein the compound is characterized in that: (a) it is capable of crossing the membrane of T-cells to enter the cytoplasm, (b) it binds to the dipeptidase activity at a concentration of below 10?8M, and thus (c) stimulates proliferation of the T-cells at that concentration.
    Type: Application
    Filed: February 13, 2004
    Publication date: January 13, 2005
    Inventors: Brigitte Huber, Tracy Schmitz, Robert Underwood
  • Potentiation of the immune response
    Patent number: 6692753
    Abstract: A method for stimulating proliferation of T-cells containing cytoplasmic post-prolyl dipeptidase activity; the method, in one aspect, involves contacting the T-cells with an organic compound at a concentration below 10−8M, wherein the compound is characterized in that: (a) it is capable of crossing the membrane of T-cells to enter the cytoplasm, (b) it binds to the dipeptidase activity at a concentration of below 10−8M, and thus (c) stimulates proliferation of the T-cells at that concentration.
    Type: Grant
    Filed: January 26, 2000
    Date of Patent: February 17, 2004
    Assignee: Trustees of Tufts College
    Inventors: Brigitte T. Huber, Tracy Schmitz, Robert Underwood
  • Treatment of HIV
    Publication number: 20030212044
    Abstract: A method for increasing immune responses of a human patient infected with HIV, involving contacting the T-cells, in vitro or in vivo, with an organic compound at a concentration effective to cause T-cell proliferation, but below an amount that causes detectable cytotoxicity.
    Type: Application
    Filed: January 7, 2003
    Publication date: November 13, 2003
    Inventors: Brigitte T. Huber, Tracy Schmitz, Robert Underwood
  • Treatment of HIV
    Patent number: 6503882
    Abstract: A method for increasing immune responses of a human patient infected with HIV, involving contacting the T-cells, in vitro or in vivo, with an organic compound at a concentration effective to cause T-cell proliferation, but below an amount that causes detectable cytotoxicity.
    Type: Grant
    Filed: January 18, 2000
    Date of Patent: January 7, 2003
    Assignee: Trustees of Tufts College
    Inventors: Brigitte T. Huber, Tracy Schmitz, Robert Underwood
  • TREATMENT OF HIV
    Publication number: 20020147130
    Abstract: A method for increasing immune responses of a human patient infected with HIV, involving contacting the T-cells, in vitro or in vivo, with an organic compound at a concentration effective to cause T-cell proliferation, but below an amount that causes detectable cytotoxicity.
    Type: Application
    Filed: January 18, 2000
    Publication date: October 10, 2002
    Inventors: Brigitte T. Huber, Tracy Schmitz, Robert Underwood
  • Potentiation of the immune response
    Publication number: 20010055777
    Abstract: A method for stimulating proliferation of T-cells containing cytoplasmic post-prolyl dipeptidase activity; the method, in one aspect, involves contacting the T-cells with an organic compound at a concentration below 10−8M, wherein the compound is characterized in that: (a) it is capable of crossing the membrane of T-cells to enter the cytoplasm, (b) it binds to the dipeptidase activity at a concentration of below 10−8M, and thus (c) stimulates proliferation of the T-cells at that concentration.
    Type: Application
    Filed: January 26, 2000
    Publication date: December 27, 2001
    Inventors: Brigitte T Huber, Tracy Schmitz, Robert Underwood
  • Treatment of HIV
    Patent number: 6100234
    Abstract: A method for increasing immune responses of a human patient infected with HIV, involving contacting the T-cells, in vitro or in vivo, with an organic compound at a concentration effective to cause T-cell proliferation, but below an amount that causes detectable cytotoxicity.
    Type: Grant
    Filed: May 7, 1997
    Date of Patent: August 8, 2000
    Assignee: Tufts University
    Inventors: Brigitte T. Huber, Tracy Schmitz, Robert Underwood
  • Potentiation of the immune response
    Patent number: 6040145
    Abstract: A method for stimulating proliferation of T-cells containing cytoplasmic post-prolyl dipeptidase activity; the method, in one aspect, involves contacting the T-cells with an organic compound at a concentration below 10.sup.-8 M, wherein the compound is characterized in that: (a) it is capable of crossing the membrane of T-cells to enter the cytoplasm, (b) it binds to the dipeptidase activity at a concentration of below 10.sup.-8 M, and thus (c) stimulates proliferation of the T-cells at that concentration.
    Type: Grant
    Filed: May 7, 1997
    Date of Patent: March 21, 2000
    Assignee: Tufts University
    Inventors: Brigitte T. Huber, Tracy Schmitz, Robert Underwood